ArticleLiver cancer2024

Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma- with Emphasis on Locoregional Therapy for Oligoprogression.

Tsung-Hao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.